联邦制药(03933)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03933 联邦制药

休市中 12-05 16:09:08

12.920

+0.080

+0.62%

最高12.940	最低12.660	成交量630.35万
今开12.800	昨收12.840	日振幅2.18%
总市值254.91亿	流通市值254.91亿	总股本19.73亿
成交额8,071万	换手率0.32%	流通股本19.73亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03933","market":"HK","secType":"STK","nameCN":"联邦制药","latestPrice":12.92,"timestamp":1764922148006,"preClose":12.84,"halted":0,"volume":6303500,"delay":0,"floatShares":1973000000,"shares":1973000000,"eps":1.6118874228796076,"marketStatus":"休市中","change":0.08,"latestTime":"12-05 16:09:08","open":12.8,"high":12.94,"low":12.66,"amount":80712911,"amplitude":0.021807,"askPrice":12.92,"askSize":372000,"bidPrice":12.89,"bidSize":16000,"shortable":3,"etf":0,"ttmEps":1.8561152256665758,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":7,"adr":0,"listingDate":1181836800000,"exchange":"SEHK","adjPreClose":12.84,"dividendRate":0.037309,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":1.27782,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03933","defaultTab":"news","newsList":[{"id":"2589402852","title":"【券商聚焦】交银国际：医药行业短期催化剂充足 长期继续看好创新主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2589402852","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589402852?lang=zh_cn&edition=full","pubTime":"2025-12-05 10:38","pubTimestamp":1764902337,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，2025年10月以来，内资通过港股通持有医药股的比例小幅下降，外资持仓从年中起亦呈回落态势，但内外资加大创新药布局的大方向不变。而外资则更积极，聚焦创新主线中的龙头及产业链上游，包括恒瑞医药、君实生物和荣昌生物等创新药，及康龙化成、药明康德和泰格医药等CXO标的。12月，行业仍有充足催化剂，包括各项学术大会、医保谈判结果公布、美联储潜在降息等，板块投资情绪有望稳中有升。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970976","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B543WZ88.USD","LU1251922891.USD","01099","BK1197","BK1500","LU0634319403.HKD","LU1969619763.USD","LU2476274720.SGD","01789","LU0640798160.USD","LU0348766576.USD","IE00BPRC5H50.USD","01530","LU0540923850.HKD","BK1588","LU2476274308.USD","LU0417516571.SGD","BK1585","LU0417516902.SGD","BK1593","BK1141","03329","IE00B5MMRT66.SGD","LU2488822045.USD","LU1303224171.USD","LU2328871848.SGD","09688","LU0348825331.USD","LU2778985437.USD","BK1617","BK1147","02228","BK1583","SG9999014674.SGD","LU2399975544.HKD","LU0417516738.SGD","03933","02367","LU0348827113.USD","02268","LU1794554557.SGD","BK1161","02196","SG9999004311.SGD","LU0588546209.SGD","LU1770034418.SGD","LU0561508036.HKD","06160","09926","HK0000165453.HKD"],"gpt_icon":1},{"id":"1121709312","title":"联邦制药国际控股（3933）11月股份月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1121709312","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121709312?lang=zh_cn&edition=full","pubTime":"2025-12-03 17:20","pubTimestamp":1764753628,"startTime":"0","endTime":"0","summary":"联邦制药国际控股有限公司（03933）于2025年12月3日披露2025年11月股份变动月报，报告期为2025年11月1日至11月30日。\n公司普通股法定及注册股本与上月一致，注册股本维持在3,800,000,000股，面值每股0.01港元，总注册股本38,000,000港元。截至11月末，已发行股份总数为1,973,026,508股，较上月底无新增发行或回购注销记录，库藏股数目仍为0股。\n本月亦无任何股份期权、可换股票据及其他类似工具的发行或变动。公司确认所有相关交易均已遵守香港联交所《上市规则》和相关法律法规。\n本次月报由公司秘书梁永康签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933"],"gpt_icon":0},{"id":"2588010862","title":"每日卖空追踪 | 联邦制药 12月03日卖空量成交59.6万股，卖空比例为12.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588010862","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588010862?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:30","pubTimestamp":1764750631,"startTime":"0","endTime":"0","summary":"联邦制药北京时间12月03日，股价较前一交易日持平，卖空量成交59.6万股，较上一交易日减少26.24%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163530978d7bf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163530978d7bf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2588082848","title":"联邦制药TUL01101片启动Ⅰ期临床 适应症为中重度特应性皮炎","url":"https://stock-news.laohu8.com/highlight/detail?id=2588082848","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588082848?lang=zh_cn&edition=full","pubTime":"2025-12-02 12:03","pubTimestamp":1764648180,"startTime":"0","endTime":"0","summary":"药物临床试验登记与信息公示平台数据显示，珠海联邦制药股份有限公司的评价不同规格TUL01101片在中国健康受试者中的相对生物利用度研究的Ⅰ期临床试验已启动。本次试验主要目的为评价TUL01101片不同处方工艺的新旧规格在健康成人受试者空腹条件下单次口服给药的药代动力学特征和相对生物利用度；次要目的为评价健康成人受试者单次口服不同处方工艺的新旧规格TUL01101片的安全性。TUL01101片为化学药物，适应症为中重度特应性皮炎。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202130122978b1235&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202130122978b1235&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2588748097","title":"每日卖空追踪 | 联邦制药 12月01日卖空量成交42.6万股，卖空比例为7.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588748097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588748097?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:30","pubTimestamp":1764577834,"startTime":"0","endTime":"0","summary":"联邦制药北京时间12月01日，涨0.23%，卖空量成交42.6万股，较上一交易日减少55.99%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116352895244986&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116352895244986&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2588774874","title":"联邦制药12月01日获主力加仓885.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588774874","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588774874?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:15","pubTimestamp":1764576958,"startTime":"0","endTime":"0","summary":"12月01日, 联邦制药股价涨0.23%，报收12.80元，成交金额7099.2万元，换手率0.28%，振幅2.27%，量比0.51。联邦制药今日主力资金净流入885.7万元，连续4日净流入，上一交易日主力净流入3.7万元。近一年数据显示，该股主力连续4日净流入后，次日上涨概率为61.54%，平均涨幅为2.79%。该股近5个交易日上涨5.92%，主力资金累计净流入2415.0万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流出2096.1万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201162125a71c6921&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201162125a71c6921&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2586237699","title":"联邦制药(03933)：注射用头孢哌酮钠舒巴坦钠通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2586237699","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586237699?lang=zh_cn&edition=full","pubTime":"2025-11-26 17:08","pubTimestamp":1764148110,"startTime":"0","endTime":"0","summary":"智通财经APP讯，联邦制药 发布公告，公司全资附属公司珠海联邦制药股份有限公司中山分公司申报的注射用头孢哌酮钠舒巴坦钠经中国国家药品监督管理局审批，通过仿制药质量和疗效一致性评价。注射用头孢哌酮钠舒巴坦钠是第三代头孢菌素类抗生素，具有广谱抗菌活性，可单独或联合用药。现时，注射用头孢哌酮钠舒巴坦钠为国家医保目录乙类药品。此外，本次获批将进一步有助于公司巩固于抗感染领域的优势地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373897.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"1178063525","title":"联邦制药 - 注射用头孢哌酮钠和舒巴坦钠通过Nmpa一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=1178063525","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178063525?lang=zh_cn&edition=full","pubTime":"2025-11-26 17:02","pubTimestamp":1764147739,"startTime":"0","endTime":"0","summary":"联邦制药 - 注射用头孢哌酮钠和舒巴坦钠通过Nmpa一致性评价","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2586262581","title":"联邦制药11月26日主力净流入584.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2586262581","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586262581?lang=zh_cn&edition=full","pubTime":"2025-11-26 16:15","pubTimestamp":1764144934,"startTime":"0","endTime":"0","summary":"11月26日, 联邦制药股价涨1.11%，报收12.75元，成交金额1.3亿元，换手率0.52%，振幅3.65%，量比0.89。联邦制药今日主力资金净流入584.3万元，上一交易日主力净流出52.1万元。该股近5个交易日上涨7.44%，主力资金累计净流入620.1万元；近20日主力资金累计净流出3867.8万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126161817a4bb5567&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126161817a4bb5567&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2586540941","title":"每日卖空追踪 | 联邦制药 11月25日卖空量成交168.4万股，卖空比例为11.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586540941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586540941?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:30","pubTimestamp":1764059433,"startTime":"0","endTime":"0","summary":"联邦制药北京时间11月25日，涨5.08%，卖空量成交168.4万股，较上一交易日减少55.82%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112516351895192e9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112516351895192e9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2586454524","title":"港股联邦制药午前涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586454524","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586454524?lang=zh_cn&edition=full","pubTime":"2025-11-25 11:52","pubTimestamp":1764042779,"startTime":"0","endTime":"0","summary":"每经AI快讯，联邦制药(03933.HK)午前涨超4%，截至发稿，涨4.08%，报59.95港元，成交额3128.21万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511253574038895.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511253574038895.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2586644311","title":"港股异动 | 联邦制药(03933)午前涨超4% 公司降糖新品备受关注 司美格鲁肽注射液预计明年上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2586644311","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586644311?lang=zh_cn&edition=full","pubTime":"2025-11-25 11:39","pubTimestamp":1764041944,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，联邦制药午前涨超4%，截至发稿，涨4.08%，报59.95港元，成交额3128.21万港元。会上，联邦制药重点展示了降糖系列产品布局，包括新近上市的利拉鲁肽注射液“联邦优利泰”，以及预计明年上市的司美格鲁肽注射液“联邦优美泰”，这些产品的推出标志着联邦制药在GLP-1靶点治疗领域取得重要进展。值得一提的是，此前，联邦制药旗下子公司联邦生物与诺和诺德就UBT251达成独家许可协议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 联邦制药(03933)午前涨超4% 公司降糖新品备受关注 司美格鲁肽注射液预计明年上市","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2585412512","title":"联邦制药参加“百企百院粤医行”医工产销对接活动横琴专场","url":"https://stock-news.laohu8.com/highlight/detail?id=2585412512","media":"联邦制药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585412512?lang=zh_cn&edition=full","pubTime":"2025-11-21 18:20","pubTimestamp":1763720431,"startTime":"0","endTime":"0","summary":"11月20日，由广东省工业和信息化厅、广东省卫生健康委员会主办的“百企百院粤医行”医工产销对接活动横琴专场在粤澳合作中医药科技产业园举行，作为横琴粤澳深度合作区生物医药重点企业代表，联邦制药参加了本次活动，助推广东省生物医药产业高质量发展。同时，他分享了联邦制药的新药研发进展、市场开发动态以及全球布局情况。联邦制药将持续深化科研创新与行业协作，为广东生物医药产业高质量发展注入新动能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121194243a708f7bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121194243a708f7bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2585125172","title":"每日卖空追踪 | 联邦制药 11月21日卖空量成交55.2万股，卖空比例为7.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585125172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585125172?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:30","pubTimestamp":1763713835,"startTime":"0","endTime":"0","summary":"联邦制药北京时间11月21日，跌2.09%，卖空量成交55.2万股，较上一交易日减少58.31%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121163526a708968f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121163526a708968f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2584908274","title":"【券商聚焦】中信建投：医药流通行业收入端稳健向好 关注回款及“十五五”规划","url":"https://stock-news.laohu8.com/highlight/detail?id=2584908274","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584908274?lang=zh_cn&edition=full","pubTime":"2025-11-20 09:20","pubTimestamp":1763601625,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投研报指，中药行业短期基数压力有望缓解，渠道库存加速出清，看好年底需求回暖，及后续基本面和估值改善机会；创新领域有助构建第二增长曲线，中药消费品公司品牌延展空间广阔。血制品行业关注“十五五”浆站建设规划及行业并购整合进展，需求端看好静丙、因子类产品需求端提升及新品研发。疫苗行业关注重磅产品销售改善情况及创新管线研发进展，政策出台及疫苗出海有望推动企业进一步发展。医药零售行业转型变革稳步推进，关注后续多元催化。医药流通行业收入端稳健向好，关注回款及“十五五”规划。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/YmUwNDEzZDkyZTQxMjdjZGQ1ZTFlYjEwODUyNTc4Njg4Nw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YmUwNDEzZDkyZTQxMjdjZGQ1ZTFlYjEwODUyNTc4Njg4Nw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1969973","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01789","BK1583","BK1100","BK1593","LU2476274720.SGD","01530","LU1961090484.USD","01099","BK1515","LU0348766576.USD","02268","02367","02228","09688","BK1585","BK1500","LU0540923850.HKD","LU1251922891.USD","BK1617","601066","BK0276","LU0307460666.USD","LU1719994722.HKD","LU0640798160.USD","LU0417516902.SGD","06160","LU1969619763.USD","BK1191","03933","LU0561508036.HKD","LU2399975544.HKD","BK1197","09939","02196","IE00B543WZ88.USD","LU0348825331.USD","LU2328871848.SGD","LU0588546209.SGD","LU1303224171.USD","BK1574","LU0417516738.SGD","09926","LU0417516571.SGD","LU2488822045.USD","LU2476274308.USD","IE00B5MMRT66.SGD","159938","BK1161","LU0348767384.USD","IE00BPRC5H50.USD"],"gpt_icon":0},{"id":"2584798519","title":"每日卖空追踪 | 联邦制药 11月19日卖空量成交113.6万股，卖空比例为8.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584798519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584798519?lang=zh_cn&edition=full","pubTime":"2025-11-19 16:30","pubTimestamp":1763541032,"startTime":"0","endTime":"0","summary":"联邦制药北京时间11月19日，涨2.22%，卖空量成交113.6万股，较上一交易日减少39.64%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511191635289772fe57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511191635289772fe57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2584798909","title":"联邦制药荣登“2025年中国创新药出海领航企业榜40强”","url":"https://stock-news.laohu8.com/highlight/detail?id=2584798909","media":"联邦制药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584798909?lang=zh_cn&edition=full","pubTime":"2025-11-19 12:35","pubTimestamp":1763526950,"startTime":"0","endTime":"0","summary":"在18日举行的医疗科技创新公司颁奖典礼上，发布了《2025年中国创新药出海领航企业榜40强》。联邦制药凭借在创新药研发、全球布局与国际化合作等方面的卓越表现，荣登“2025年中国创新药出海领航企业榜40强”，位列第10名。这不仅是对联邦制药创新实力与全球化战略的认可，更是对中国创新药出海探索的鼓舞。联邦制药将继续加快科研创新与国际合作，助力中国创新药在世界舞台释放“向善”的医疗价值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119124951a7036d4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119124951a7036d4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1574","BK1191","BK1161","06978"],"gpt_icon":0},{"id":"2584404609","title":"每日卖空追踪 | 联邦制药 11月17日卖空量成交89.2万股，卖空比例为3.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584404609","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584404609?lang=zh_cn&edition=full","pubTime":"2025-11-17 16:30","pubTimestamp":1763368233,"startTime":"0","endTime":"0","summary":"联邦制药北京时间11月17日，跌6.13%，卖空量成交89.2万股，较上一交易日减少67.25%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117163521a4a72e96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117163521a4a72e96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2584459611","title":"港股创新药概念股持续下跌 联邦制药跌超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584459611","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584459611?lang=zh_cn&edition=full","pubTime":"2025-11-17 14:05","pubTimestamp":1763359521,"startTime":"0","endTime":"0","summary":"每经AI快讯，港股创新药概念股持续下跌，联邦制药跌超8%，晶泰控股、巨子生物、三生制药、中国生物制药等跟跌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511173566172317.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511173566172317.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["03933","06978","BK1161","BK1191","BK1574"],"gpt_icon":0},{"id":"2584092846","title":"联邦制药盘中异动 早盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584092846","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584092846?lang=zh_cn&edition=full","pubTime":"2025-11-17 11:27","pubTimestamp":1763350035,"startTime":"0","endTime":"0","summary":"2025年11月17日早盘11时27分，联邦制药股票出现异动，股价急速跳水5.04%。截至发稿，该股报12.240港元/股，成交量900.022万股，换手率0.46%，振幅5.59%。联邦制药股票所在的药品行业中，整体跌幅为0.62%。其相关个股中，长风药业、三爱健康集团、联康生物科技集团涨幅较大，振幅较大的相关个股有精优药业、联邦制药、中国同辐，振幅分别为7.69%、5.59%、5.47%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117112715a4a696b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117112715a4a696b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tul.com.cn","stockEarnings":[{"period":"1week","weight":0.0117},{"period":"1month","weight":0.0386},{"period":"3month","weight":-0.2649},{"period":"6month","weight":-0.1224},{"period":"1year","weight":0.2534},{"period":"ytd","weight":0.0892}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0964},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.3004}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"联邦制药国际控股有限公司是一家投资控股公司，主要从事销售中间体产品、原料药及制剂产品业务。该公司通过三个业务部门运营业务。中间体部从事销售中间体产品业务。原料药部从事销售原料药业务。制剂产品部从事销售抗生素制剂产品、非抗生素制剂产品及空心胶囊业务。该公司通过其子公司还从事制造及销售有机化肥业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.036412},{"month":2,"riseRate":0.722222,"avgChangeRate":0.07509},{"month":3,"riseRate":0.666667,"avgChangeRate":0.040428},{"month":4,"riseRate":0.611111,"avgChangeRate":0.081119},{"month":5,"riseRate":0.666667,"avgChangeRate":0.040685},{"month":6,"riseRate":0.277778,"avgChangeRate":-0.012388},{"month":7,"riseRate":0.526316,"avgChangeRate":0.011895},{"month":8,"riseRate":0.473684,"avgChangeRate":0.025474},{"month":9,"riseRate":0.421053,"avgChangeRate":-0.006971},{"month":10,"riseRate":0.631579,"avgChangeRate":-0.000903},{"month":11,"riseRate":0.473684,"avgChangeRate":-0.023163},{"month":12,"riseRate":0.473684,"avgChangeRate":0.016635}],"exchange":"SEHK","name":"联邦制药","nameEN":"UNITED LAB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"联邦制药(03933)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供联邦制药(03933)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"联邦制药,03933,联邦制药股票,联邦制药股票老虎,联邦制药股票老虎国际,联邦制药行情,联邦制药股票行情,联邦制药股价,联邦制药股市,联邦制药股票价格,联邦制药股票交易,联邦制药股票购买,联邦制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"联邦制药(03933)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供联邦制药(03933)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}